Physician profile
Diana E Small
NPI 1801900741
$863.69
in general payments reported to CMS, 2019-2025
14 companies · $229 in 2025
The $229 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.97 · 2020: $16.99 · 2021: $73.05 · 2022: $90.60 · 2023: $142 · 2024: $282 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $159.36 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Corium, LLC | $148.05 | 2023-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $121.86 | 2022-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $84.84 | 2022-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $62.60 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $59.23 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $53.13 | 2025 | Jornay Pm |
| Pfizer INC. | $49.92 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.18 | 2021-2022 | |
| Seqirus USA INC | $19.28 | 2022 | |
| Sanofi Pasteur INC. | $18.16 | 2024 | |
| Adlon Therapeutics L.P. | $16.99 | 2020 | |
| Glaxosmithkline, LLC. | $16.31 | 2021 | |
| Ironwood Pharmaceuticals, INC | $15.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.